Rituximab Biosimilars Market: In-Depth Analysis, Emerging Trends,...

adicionou um novo artigo News

2024-09-19 04:28:52 - Traduzir -

The rituximab biosimilars market is gaining substantial momentum due to its critical role in treating autoimmune diseases and various types of cancer, particularly non-Hodgkin’s lymphoma and chronic lymphocytic leukemia. Rituximab, a monoclonal antibody, has been a cornerstone therapy for these conditions, but the high cost of branded biologics has been a significant barrier to access for...

0 Comentários 0 Compartilhamentos 3KB Visualizações 0 Anterior